Fragment-to-Lead Medicinal Chemistry Publications in 2019

J Med Chem. 2020 Dec 24;63(24):15494-15507. doi: 10.1021/acs.jmedchem.0c01608. Epub 2020 Nov 23.


Fragment-based drug discovery (FBDD) has grown and matured to a point where it is valuable to keep track of its extent and details of application. This Perspective summarizes successful fragment-to-lead stories published in 2019. It is the fifth in a series that started with literature published in 2015. The analysis of screening methods, optimization strategies, and molecular properties of hits and leads are presented in the hope of informing best practices for FBDD. Moreover, FBDD is constantly evolving, and the latest technologies and emerging trends are summarized. These include covalent FBDD, FBDD for the stabilization of proteins or protein-protein interactions, FBDD for enzyme activators, new screening technologies, and advances in library design and chemical synthesis.

MeSH terms

  • Chemistry, Pharmaceutical* / trends
  • Drug Discovery*
  • Humans
  • Protein Interaction Domains and Motifs
  • Protein Stability
  • Proteins / chemistry
  • Proteins / metabolism
  • Publications*


  • Proteins